Tania specialises in the drafting and prosecution of patent applications in a range of biotechnology-related fields, including immunology, immunotherapy, vaccines, medical diagnostics, stem cells, cell biology, microbiology, molecular biology, and genetically-modified plants. Tania has significant experience in other non-contentious patent matters such as patentability, validity and infringement analyses and due diligence, as well as contentious patent matters, including patent opposition proceedings both in Australia and in other jurisdictions. She also advises on patent strategy and IP portfolio management with a view to her client’s commercial aims and imperatives.
Following her graduation from the University of Melbourne with a PhD in immunology and microbiology, Tania completed a postdoctoral fellowship at the Center for Biologics Evaluation and Research at the Food and Drug Administration (FDA) in Bethesda, U.S.A, studying hepatitis C virus pathogenesis and immunology. Tania then took up a position at the FDA as a Visiting Scientist: a combined scientific and regulatory role that included the review of Investigational New Drug (IND) applications. Tania moved in to the field of intellectual property in 2005 and spent 5 years working as a patent professional in San Diego, U.S.A. at firms such as Fish & Richardson P.C. before returning to Australia to continue her career at Davies Collison Cave, gaining her Australian and New Zealand (now Trans-Tasman) attorney qualifications in 2013.